The Pharma X Next Conference & Awards 2026 brought together leading voices from across the global pharmaceutical, biotechnology, and healthcare industries for two days of insight-driven discussions, strategic collaboration, and recognition of industry excellence.
Among the distinguished leaders recognized during the event, Serena Saggini stood out for her remarkable contribution to pharmaceutical commercialization, oncology leadership, and biotech innovation. With more than 25 years of experience in the global life sciences industry, Serena has built a career defined by strategic vision, commercial excellence, and a deep commitment to improving patient access to innovative therapies.
Currently serving as Director at Sophos Biotech S.r.l. in Milan, Italy, Serena continues to play a key role in driving commercial growth within the Oncology sector while contributing to the broader business development strategy of the company.
A Respected Leader Across Global Pharma and Biotechnology
Over the course of her distinguished career, Serena Saggini has developed extensive expertise across some of the most critical and complex therapeutic areas in healthcare, including Oncology, Biotechnology, Rare Diseases, Central Nervous System disorders, Cardiology, Nephrology, and Women’s Health.
Her leadership journey spans several globally recognized pharmaceutical organizations, including Sanofi Genzyme, Ferring Pharmaceuticals, GSK, and Schering-Plough, where she held senior commercial and strategic leadership positions.
During her tenure at Sanofi Genzyme, Serena led multiple business units focused on rare diseases such as Fabry Disease, Pompe Disease, and MPS, as well as Endocrine Oncology. In these roles, she successfully managed large commercial operations and multidisciplinary teams while helping expand access to innovative treatments for patients across Italy.
Her expertise extends across:
- Commercial strategy
- Market access
- Sales leadership
- Business development
- Oncology commercialization
- Tenders coordination
- Healthcare partnerships
- Market expansion initiatives
What distinguishes Serena’s leadership style is her ability to combine strategic business thinking with a strong understanding of patient-centered healthcare innovation. Throughout her career, she has consistently focused on building sustainable growth strategies while strengthening collaboration between pharmaceutical companies, healthcare institutions, and industry stakeholders.
Driving Innovation and Commercial Excellence
Serena has also demonstrated exceptional capability in building and structuring new pharmaceutical business operations. One of her notable achievements includes the creation of an Onco-Hematology European team for a Japanese pharmaceutical company — an initiative that reflected her ability to lead international expansion efforts while navigating complex market environments.
Her strategic insight into oncology commercialization and biotech growth has made her a highly respected voice within the industry. She has actively contributed to numerous international pharmaceutical conferences and executive forums, where she has shared expertise on:
- Commercial excellence
- Sales force effectiveness
- Digital strategy in pharma
- Market access innovation
- Leadership in biotech commercialization
Her participation in global industry events has reinforced her reputation as a forward-thinking executive capable of aligning innovation, business strategy, and healthcare outcomes.
A Thought-Provoking Panel Discussion at Pharma X Next 2026
At Pharma X Next Conference & Awards 2026, Serena Saggini participated as a featured speaker in the panel discussion:
“The Future of Pharma: Expert Insights”
The session brought together leading pharmaceutical executives and industry experts to discuss the evolving landscape of global healthcare, biotechnology innovation, commercialization strategies, and the future direction of the pharmaceutical industry.
During the discussion, Serena shared valuable perspectives shaped by decades of hands-on leadership experience in rare diseases, oncology, and biotech commercialization. Her insights emphasized the growing importance of cross-functional integration, patient-centered innovation, digital transformation, and strategic collaboration in shaping the future of pharmaceutical organizations.
Her contribution to the panel highlighted how pharmaceutical companies must evolve beyond traditional commercial models to address increasingly complex healthcare ecosystems, emerging technologies, and rapidly changing patient needs.
The session resonated strongly with conference attendees, offering practical and strategic insights into the opportunities and challenges that will define the next era of pharma and biotech innovation.
Honored with the Excellence in Pharma Industry for Strategic Leadership in Oncology & Biotech Award
In recognition of her outstanding leadership and contributions to the pharmaceutical and biotechnology sectors, Serena Saggini was honored at the Pharma X Next Conference & Awards 2026 with the prestigious:
Excellence in Pharma Industry for Strategic Leadership in Oncology & Biotech Award
The award celebrated her long-standing impact on oncology commercialization, biotech growth, rare disease leadership, and strategic pharmaceutical innovation.
It also recognized her role in driving commercial excellence across multiple therapeutic areas while helping improve access to innovative healthcare solutions for patients worldwide.
Serena’s recognition at Pharma X Next reflects the importance of visionary leaders who can successfully bridge science, strategy, commercialization, and patient impact in today’s rapidly evolving healthcare landscape.
Leadership That Continues to Shape the Future of Healthcare
In an industry undergoing profound transformation driven by biotechnology advances, precision medicine, digital innovation, and evolving patient expectations, Serena Saggini represents the type of leadership the pharmaceutical sector increasingly needs.
Her career demonstrates how strategic leadership, operational excellence, and a commitment to innovation can work together to create sustainable growth and meaningful healthcare impact.
With her extensive experience across global pharma organizations, rare disease markets, oncology strategy, and biotech commercialization, Serena continues to contribute to the advancement of healthcare and life sciences at an international level.
Pharma X Next Conference & Awards is a global platform that brings together pharmaceutical leaders, biotech innovators, healthcare executives, researchers, and industry pioneers to celebrate excellence and explore the future of healthcare innovation.
Reach us on WhatsApp